1. $REGN This is a watcher this tested the support of the $481.06

  2. $BIIB vs. $REGN Head to Head http://www.cmlviz.com/cmld3b/lite.php?app=tt&tickers=BIIB|REGN&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)&referral=ST

  3. @ftatrader $IBD Top 20: $AMBA $AHS $CBM $ELLI $PAYC $MANH $VRX $ALK $HAWK $ULTA $TSS $ORLY $EW $UVE $ICLR $REGN $SBUX $AVGO $CELG $CMG

  4. $IBD Top 20: $AMBA $AHS $CBM $ELLI $PAYC $MANH $VRX $ALK $HAWK $ULTA $TSS $ORLY $EW $UVE $ICLR $REGN $SBUX $AVGO $CELG $CMG

  5. NEWS Worthy: Gilead & Amgen Account for Nearly 75% of the Biotech Profit Pool Read more at Barron s $AMGN $BIIB &CELG $GILD $REGN $ALXN

  6. $GILD vs. $REGN Head to Head http://www.cmlviz.com/cmld3b/lite.php?app=tt&tickers=GILD|REGN&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)&referral=ST

  7. 💊Biotech at the close $BIB ⬆ 1 $IBB ⬆ 2 $XBI ⬆ 4 $AMGN $BIIB $CELG $GILD $REGN $ABBV $ACAD $ACT $AGN $AKRX $ALGN

  8. $ARIA $REGN would easily offer 2.6B or more for ARIA from what i understand. Waiting to see counter offers.

  9. $BIIB vs. $REGN Head to Head http://www.cmlviz.com/cmld3b/lite.php?app=tt&tickers=BIIB|REGN&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)&referral=ST

  10. NEWS Worthy: The Best Way to Buy Biotech Stocks $AMGN $BIIB $CELG $GILD $REGN $IBB $BIB $FBT $XBI

  11. $AMGN Repatha approval similar to $REGN Praluent: good 4 patients don t respond to max tolerated statins. Priced $14k/yr just under Praluent

  12. Gilead, Biogen & Regeneron Pharmaceuticals: Morgan Stanley Sees Opportunity - http://www.bidnessetc.com/51282-gilead-sciences-inc-biogen-inc-regeneron-pharmaceuticals-morgan-stanley-se/?utm_content=bufferdec91&utm_medium=social&utm_source=plus.google.com&utm_campaign=buffer $BIIB $GILD $REGN

  13. $ESPR ETC-1002 is an attractive asset to big pharma after amgen $AMGN and $REGN drug approval. Watch for partnership or buyout

  14. $SNY $REGN Praluent label: http://products.sanofi.us/praluent/praluent.pdf

  15. FDA approves Amgen cholesterol drug Repatha $AMGN $REGN

  16. News worthy: Cramer: China could cause biotech stocks to plunge $BIB $IBB $AMGN $BIIB $CELG $GILD $REGN

  17. Interactive Chart -> http://www.cmlviz.com/cmld3b/lite.php?app=mm&tickers=REGN&metrics=Revenue+(TTM+US$+Millions)|Revenue+(TTM+US$+Millions)&start_date=03/31/2000&end_date=06/30/2015&show_line=false&graph_only=0 $REGN Revenue is Growing.

  18. $AMGN prices Repatha at $14,100 vs $REGN s $14,600 for Praluent

  19. $REGN Last: 538.00 Change: +2.53 (0.47%) Volume: 752,368 Put volume: 1,371 Call volume: 1,409 Put:Call Ratio: 0.97

  20. 💊Biotech at the close $BIB ⬆ 3 $IBB ⬆ 9 $AMGN $BIIB $CELG $GILD $REGN $ABBV $ACAD $ACT $AGN $AKRX $ALGN $ALNY $ANAC

  21. $REGN a short if $amg gets FDA approval?

  22. $GALE will be $REGN in 3 years...load up now kiddos.

  23. $REGN We just have to be patient

  24. $REGN I don t get it either ? I m holding there is no way this is going down a lot.

  25. $REGN is red?